Is intravenous albumin a placebo?

Improved work capacity at altitude by transfusional polycythemia.

The Journal of sports medicine and physical fitness·2013

A propos time and autoimmunity.

Clinical reviews in allergy & immunology·2007

Asymmetry alters immune-partner relationship.

Cellular and molecular biology (Noisy-le-Grand, France)·2004

Fibrosis regression induced by intravenous gammaglobulin treatment.

Annals of the rheumatic diseases·2003

High dose intravenous immunoglobulin repertoire versus anti-D. Disproportions in quantity and quality.

Cellular and molecular biology (Noisy-le-Grand, France)·2002

IVIG-pools: regulatory gifts--transiting from harmony toward harmonious immunoglobulins: why? and why not?

Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis·2002

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Lancet (London, England)·2026

Multivessel coronary artery bypass grafting via small thoracotomy versus sternotomy (MIST): an investigator-initiated, international, open-label, randomised controlled trial.

Lancet (London, England)·2026

Efficacy and safety of once-weekly subcutaneous zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Lancet (London, England)·2026

Efficacy and safety of once-daily oral zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in adults with type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Lancet (London, England)·2026

Gastrointestinal adverse events related to monoclonal antibodies: A comprehensive evaluation of data from the FDA Adverse Event Reporting System database.

Indian journal of pharmacology·2026

SWAP70 alleviates brain damage and neuroinflammation induced by cerebral ischemia-reperfusion by inhibiting autophagy.

General physiology and biophysics·2026

Divergence between initial and cumulative manifestations in systemic lupus erythematosus: effect of age and sex in a prospective lupus cohort from Pakistan.

Annals of medicine and surgery (2012)·2026

Association between serum anti-granulocyte-macrophage colony-stimulating factor autoantibodies and nintedanib-induced diarrhea in interstitial lung disease: a retrospective study.

Journal of thoracic disease·2026

Incidental mass found on screening colonoscopy.

Journal of surgical case reports·2026

Immunocyte phenotypes underlying the causal autoimmune features in narcolepsy type 1.

Journal of thoracic disease·2026

Related Experiment Videos

Is intravenous albumin a placebo?

Related Concept Videos

Improved work capacity at altitude by transfusional polycythemia.

A propos time and autoimmunity.

Asymmetry alters immune-partner relationship.

Fibrosis regression induced by intravenous gammaglobulin treatment.

High dose intravenous immunoglobulin repertoire versus anti-D. Disproportions in quantity and quality.

IVIG-pools: regulatory gifts--transiting from harmony toward harmonious immunoglobulins: why? and why not?

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Multivessel coronary artery bypass grafting via small thoracotomy versus sternotomy (MIST): an investigator-initiated, international, open-label, randomised controlled trial.

Efficacy and safety of once-weekly subcutaneous zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Efficacy and safety of once-daily oral zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in adults with type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Gastrointestinal adverse events related to monoclonal antibodies: A comprehensive evaluation of data from the FDA Adverse Event Reporting System database.

SWAP70 alleviates brain damage and neuroinflammation induced by cerebral ischemia-reperfusion by inhibiting autophagy.

Divergence between initial and cumulative manifestations in systemic lupus erythematosus: effect of age and sex in a prospective lupus cohort from Pakistan.

Association between serum anti-granulocyte-macrophage colony-stimulating factor autoantibodies and nintedanib-induced diarrhea in interstitial lung disease: a retrospective study.

Incidental mass found on screening colonoscopy.

Immunocyte phenotypes underlying the causal autoimmune features in narcolepsy type 1.

Related Experiment Videos

Is intravenous albumin a placebo?

Related Concept Videos

Related Articles